No Detail Found!

Antimicrobial and synergistic activity of thiazoline derivatives in combination with conventional antibiotics against multidrug resistant Staphylococcus aureus isolated from abscess drainage samples

Author(s)
Muhammad Amir Khan Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan; Department of Pharmacology, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan
Shaukat Ali Dow College of Biotechnology, Dow University of Health Sciences,Karachi,Pakistan
Sumbul Shamim Department of Pharmacology, Dow College of Pharmacy, Dow University of Health Sciences,Karachi,Pakistan
Nazia Ahmed Dow Research Institute of Biotechnology & Biomedical Sciences, Dow University of Health Sciences,Karachi,Pakistan
Mushtaq Hussain Dow College of Biotechnology, Dow University of Health Sciences,Karachi,Pakistan
Saba Farooq National Institute of Virology, International Center for Chemical and Biological Sciences, University of Karachi,Karachi,Pakistan
Sadaf Khan Dow College of Biotechnology, Dow University of Health Sciences,Karachi,Pakistan
Abstract
Emergence and spread of multidrug resistant (MDR) Staphylococcus aureus strains is becoming major challenge in treatment of soft tissue infections. This study aimed to explore antimicrobial and synergistic antimicrobial potential of three commercially available thiazoline derivatives (2-amino-2-thiazoline, 2-thiazoline-2-thiol and 2-acetyl2-thiazoline) against MDR Staphylococcus aureus strains isolated from abscess drainage samples (n=20). MDR Staphylococcus aureus isolates were identified by Kirby-Bauer disk diffusion assay and were further subjected to molecular identification by 16srRNA amplification and DNA sequencing. Minimum Inhibitory Concentration (MIC) values of test compounds and antibiotics (0.25-512µg/mL) were measured and subsequently, synergism performed to calculate Fractional Inhibitory Concentration (FIC) index. Out of twenty Staphylococcus aureus isolates, sixteen (80%) were found to be MDR whereas four (20%) were Non-MDR. Moxifloxacin and vancomycine were found most effective antibiotics, inhibiting 100% (n=20) and 95% (n=19) strains respectively. Antimicrobial activity of 2amino-2-thiazoline (MIC: 32µg/mL), 2-thiazoline-2-thiol (MIC: 64µg/mL) and 2-acetyl-2-thiazoline (MIC: 32µg/mL) was found significant against all ten tested MDR strains. Synergistic combinations of thiazoline derivatives with test antibiotics reduced MIC values significantly. Therefore, combination of tested thiazoline derivatives with antibiotics could be used as alternative therapeutic approach to treat soft tissue infections caused by MDR Staphylococcus aureus after further pre-clinical and clinical studies.
Publication Details
Page(s) 2331-2339
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP5, Year: 2020

Request the full text from PASTIC

Keywords
Antibiotics, Multidrug resistance, Staphylococcus aureus, Synergism, Thiazoline derivatives
References
Ahaduzzaman M,Hassan M M M,Islam SKMA,Uddin I .2014 .Antimicrobial resistance pattern against Staphylococcus aureus in environmental effluents. Res. J. Vet, 2(1) : 13-16.
Althagafi I,El-Metwaly N,Farghaly TA .2019 .New series of thiazole derivatives: Synthesis, structural elucidation, antimicrobial activity, molecular modeling and MOE docking. , 24(9) : 1741.
Altintop MD,Kaplancikli ZA,Ciftci GA,Demirel R .2014 .Synthesis and biological evaluation of thiazoline derivatives as new antimicrobial and anticancer agents. Eur. J. Med, 74 : 264-77.
Cheesman MJ,Ilanko A,Blonk B,Cock IE B .2017 .Developing new antimicrobial therapies: Are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution?. Pharmacognosy reviews., 11(22) : 57.
CLSI .2008 .Abbreviated Identification of Bacteria and Yeast; Approved Guidelines Second Edition. CLSI Document M35-A2, : .
CLSI .2019 .Performance Standards/or Antimicrobial Susceptibility Testing. CLSI supplement MlOO, : .
Cos P,Vlietinck AJ,Berghe DV,Maes L DV .2006 .Anti-infective potential of natural products: How to develop a stronger in vitro '-porfo-ocfoncept. J Ethnopharmacol, 106(3) : 290-302.
Esposito S,Noviello S,Leone S S .2016 .Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis, 29(2) : 109-15.
Farooq S,Wahab AT,Fozing CD,Rahman AU,Choudhary MI .2014 .Artonin I inhibits multidrug resistance in Staphylococcus aureus and potentiates the action of inactive antibiotics in vitro. J Appl Microbiol, 117(4) : 996-1011.
Gajdács M .2019 .The continuing threat of methicillinresistant Staphylococcus aureus. , 8(2) : 52.
Ghasemi B,Sanjarani G,Sanjarani Z,Majidiani H Z .2015 .Evaluation of anti-bacterial effects of some novel thiazole and imidazole derivatives against some pathogenic bacteria. Iran J Microbiol., 7, (5) : 281-286.
Gill RK,Rawal RK,Bariwal J .2015 .Recent advances in the chemistry and biology of benzothiazoles. , 348 : 155-178.
Guo N,Zhao X,Li W,Shi C,Meng R,Yu L Z .2015 .The synergy of berberine chloride and totarol against Staphylococcus aureus grown in planktonic and biofilm cultures. Journal of medical microbiology., 64(8) : 891-900.
Gurung RR,Maharjan P,Chhetri GG .2020 .Antibiotic resistance pattern of Staphylococcus aureus with reference to MRSA isolates from pediatric patients. Future Science OA. , 6(4) : FSO464.
Laxminarayan R,Duse A,Wattal C,Zaidi A,Wertheim H,Sumpradit N,Vlieghe E,Hara GL,Gould IM,Goossens H,Greko C H .2013 .Antibiotic resistance the need for global solutions. Lancet Infect Dis, 13(12) : 1057-1098.
Mohammad H,Mayhoub AS,Cushman M,Seleem MN M .2015 .Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci. J Antibiot, 68(4) : 259-66.
Niederstebruch N,Sixt D,Benda B,Banboye N B .2017 .A suitable blood agar containing human blood especially for the use in laboratories of developing countries. J Infect Dev Ctries, 11(05) : 399-406.
Odds FC .2003 .Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother., 52(1) : 1.
Pantosti A,Venditti M .2009 .What is MRSA? Eur Respir J. , 34(5) : 1190-6.
Sadek B,Al-Tabakha MM,Fahelelbom KMS .2011 .Antimicrobial prospect of newly synthesized 1,3- thiazole derivatives. , 16(11) : 9386-96.
Stevens DL,Bisno AL,Chambers HF,Dellinger EP,Goldstein EJ,Gorbach SL,Hirschmann JV,Kaplan SL,Montoya JG,Wade JC .2014 .Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis, 59(2) : e10-52.
Tiwari HK,Sen MR .2006 .Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis. , 6(1) : 156.
Ullah A,Qasim M,Rahman H,Khan J,Haroon M,Muhammad N,Khan A,Muhammad N A .2016 .High frequency of methicillin-resistant Staphylococcus aureus in Peshawar Region of Pakistan. , 5(1) : 600.
Wang H,Cheng H,Wang F,Wei D,Wang X .2010 .-diphenyl tetrazolium bromide (MTT) reduction assay for evaluating the viability of Escherichia coli cells. J Microbiol Methods., 82(3) : 330-3.
Yurttaş LO,zkay Y,Karaca Gençer H and Acar U Y .2015 .Synthesis of some new thiazole derivatives and their biological activity evaluation. J CHEM-NY., : .
0

Citations

0

Downloads

12

Views